Literature DB >> 22035178

ADAM33 gene polymorphisms associate with asthma susceptibility and severity in East China han population.

Zhijun Jie1, Zhilin Hu, Chunxue Bai, Meiling Jin.   

Abstract

OBJECTIVE: Multiple genetic and environmental factors impact the pathogenesis of asthma. ADAM33 (a disintegrin and metalloproteinase domain 33) represents a novel susceptibility gene for asthma in several diverse populations. The aim of this study was to determine whether single nucleotide polymorphisms (SNPs) of the ADAM33 gene associate with asthma susceptibility and severity in the Chinese Han population.
METHODS: A total of 224 subjects were enrolled, including 74 normal controls and 150 asthmatic patients. The asthmatic enrollees were further categorized into high- or low-severity groups according to the percentage of forced expiratory volume in 1 second of predicted value, symptoms, nighttime awakening, requirement for short-acting β2-agonist, and interference with normal activities. Six SNPs (F + 1, ST + 4, S1, S2, T1, and T2) in ADAM33 were genotyped using the polymerase chain restriction fragment length polymorphism method.
RESULTS: Three SNPs (F + 1, T1, and T2) of ADAM33 were found to have significant associations with asthma in the study population (p = .0058-.0067). The allele frequencies of two SNPs (F + 1, T1) in both the low- and high-severity groups were significantly different from the allele frequency in the control group. The allelic frequency of the T2 SNP was significantly different from that of the control group only in the high-severity group (p = .0081). Haplotype analysis demonstrated that the frequency of 7575G, 12433T, and 12462C (GTC haplotype) is higher in healthy controls than amongst asthma patients (78.4% vs. 61.8%, p = .0004).
CONCLUSIONS: Polymorphisms of the ADAM33 gene associate with asthma susceptibility in the east China Han population, and the genetic association is stronger in high-severity asthmatics.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22035178     DOI: 10.3109/02770903.2011.624233

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  6 in total

Review 1.  Evaluation and treatment of critical asthma syndrome in children.

Authors:  Alexander Wade; Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2015-02       Impact factor: 8.667

2.  Association between ADAM33 T1 polymorphism and susceptibility to asthma in Asians.

Authors:  Young Ho Lee; Gwan Gyu Song
Journal:  Inflamm Res       Date:  2012-08-01       Impact factor: 4.575

3.  T1 and T2 ADAM33 single nucleotide polymorphisms and the risk of childhood asthma in a Saudi Arabian population: a pilot study.

Authors:  Arwa Ishaq Al-Khayyat; Mohammed Al-Anazi; Arjumand Warsy; Alejandro Vazquez-Tello; Abdullah Mohammed Alamri; Rabih Halwani; Abdullah Alangari; Abdurrahman Al-Frayh; Qutayba Hamid; Saleh Al-Muhsen
Journal:  Ann Saudi Med       Date:  2012 Sep-Oct       Impact factor: 1.526

Review 4.  A review of epigenetic changes in asthma: methylation and acetylation.

Authors:  Mojgan Sheikhpour; Mobina Maleki; Maryam Ebrahimi Vargoorani; Vahid Amiri
Journal:  Clin Epigenetics       Date:  2021-03-29       Impact factor: 6.551

5.  ADAM33 polymorphisms are associated with asthma and a distinctive palm dermatoglyphic pattern.

Authors:  Weilin Xue; Wei Han; Zhao-Shan Zhou
Journal:  Mol Med Rep       Date:  2013-10-14       Impact factor: 2.952

Review 6.  ADAM metallopeptidase domain 33 (ADAM33): a promising target for asthma.

Authors:  Priya Tripathi; Shally Awasthi; Peisong Gao
Journal:  Mediators Inflamm       Date:  2014-04-10       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.